Symbiotec Pharmalab Ltd PB

PB Ratio of Symbiotec Pharmalab Ltd

Image

Symbiotec Pharmalab Ltd

NSE: SYMBIOTEC

PB Ratio

5.7

Last updated on: Sep 29, 2026

Key Highlights

  • The latest PB Ratio of Symbiotec Pharmalab Ltd is 5.7.
  • The PB ratio of the Symbiotec Pharmalab Ltd is above 3 which indicates that the stock is overvalued but this is common in high-growing sectors The P/B Ratio of Symbiotec Pharmalab Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years .

Historical P/B Ratio of Symbiotec Pharmalab Ltd

No data available

Company Fundamentals for null

Market Cap

7,353 Cr

EPS

18.0

P/E Ratio (TTM)

63.8

P/B Ratio (TTM)

5.7

Day’s High

1196.05

Day’s Low

1138.65

DTE

0.3

ROE

9.6

52 Week High

1196.05

52 Week Low

933.8

ROCE

11.6

Market Price of Symbiotec Pharmalab Ltd

1M

1Y

3Y

5Y

Monitoring Symbiotec Pharmalab Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
29 Sep 20261144.35
28 Sep 20261056.75
25 Sep 20261002.55
24 Sep 20261024.95
23 Sep 20261062.15
22 Sep 20261121.25
21 Sep 20261158.45
18 Sep 20261093.25
17 Sep 20261046.8
16 Sep 20261042.5

SWOT Analysis Of Symbiotec Pharmalab Ltd

Strength

1

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Symbiotec Pharmalab Ltd

Asset Value vs Market Value of Symbiotec Pharmalab Ltd

Market Value

₹ 0

Asset Value

₹ 0

* All values are in ₹ crores

PB Ratio of Symbiotec Pharmalab Ltd Explained

₹7353

Market cap

₹202

Book Value per Share

5.7X

PB Ratio

Historical Market Cap of Symbiotec Pharmalab Ltd

Market Cap

No data available

* All values are in ₹ crore

Historical Revenue, EBITDA and Net Profit of Symbiotec Pharmalab Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in ₹ crore

Dividend Payout Over Time

No data available

Symbiotec Pharmalab Ltd News Hub

Symbiotec Pharmalab to announce Quarterly Result

Symbiotec Pharmalab will hold a meeting of the Board of Directors of the Company on 21 September 202

Read more

12 Sept 26

Symbiotec Pharmalab posts nearly 53% YoY fall in Q1 PAT

Reported EBIDTA declined by 22.1% year-on-year (YoY) to Rs 45.2 crore while reported EBIDTA margin c

Read more

22 Sept 26

Symbiotec Pharmalab IPO ends with 71.26 times subcription

The initial public offer of Symbiotec Pharmalab received bids for 93,52,49,700 shares as against 1,3

Read more

28 Aug 26

Symbiotec Pharmalab consolidated net profit declines 53.01% in the June 2026 quarter

Net profit of Symbiotec Pharmalab declined 53.01% to Rs 14.06 crore in the quarter ended June 2026 a

Read more

23 Sept 26

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PB Ratio of null

What is the PB ratio of Symbiotec Pharmalab Ltd?

The current PB ratio of Symbiotec Pharmalab Ltd is 5.66. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Symbiotec Pharmalab Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Symbiotec Pharmalab Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Symbiotec Pharmalab Ltd calculated?

The PB ratio of Symbiotec Pharmalab Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Symbiotec Pharmalab Ltd?

A high PB ratio suggests that Symbiotec Pharmalab Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Symbiotec Pharmalab Ltd?

A low PB ratio of Symbiotec Pharmalab Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Symbiotec Pharmalab Ltd PB Ratio change over time?

Yes, the PB ratio of Symbiotec Pharmalab Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions